Stock Ticker

  • Loading stock data...

Thoratec Corporation (NASDAQ:THOR): Goldman Sachs Group Inc (NYSE:GS) Sees Room to step up Execution To Match Clinical Progress

Boston, MA 10/13/2014 (wallstreetpr) – Thoratec Corporation (NASDAQ:THOR) has the scope to step up its execution to match its clinical progress, which the company was leading, Goldman Sachs Group Inc (NYSE:GS) believes. Share Gain The brokerage believes that the Thoratec Corporation (NASDAQ:THOR)’s CEO, Keith Grossman, has raised the interest level of the investors after the […]

Abbott Laboratories (NYSE:ABT): Goldman Sachs Group Inc (NYSE:GS) Sees Nutritional Business As Key Driver Of Growth

Boston, MA 10/13/2014 (wallstreetpr) – Goldman Sachs Group Inc (NYSE:GS) expects nutritional business as a key driver for growth opportunities for Abbott Laboratories (NYSE:ABT). The brokerage believes that the company could use the untapped business opportunities in the sector for its future uptick. China Untapped Analyst David Roman said that there were untapped geographies for […]

Stryker Corporation (NYSE:SYK): Goldman Sachs Group Inc (NYSE:GS) Sees More Potential Drivers Of Upside Rewards

Boston, MA 09/19/2014 (wallstreetpr) – Financial advisor Goldman Sachs Group Inc (NYSE:GS) believes that there are a lot of potential drivers of upside rewards in medical technology company, Stryker Corporation (NYSE:SYK). The brokerage expects the company to gain from improvements in the macro environment for additional growth tailwinds and favorable valuation. Analyst Meeting The investment […]

Goldman Sachs Group Inc (NYSE:GS) Key Takeaways From American Society Of Radiation Oncology Conference

Boston, MA 09/19/2014 (wallstreetpr) – Investment advisor, Goldman Sachs Group Inc (NYSSE:GS), has provided key takeaways from the American Society of Radiation Oncology or ASTRO conference. It sees the environment in the U.S. as stable as far as overall radiation oncology market was concerned since there was no change in the number of treatment vaults […]

Goldman Sachs Group Inc (NYSE:GS) Key Takeaways from Transcatheter Cardiovascular Therapeutics Conference

Boston, MA 09/16/2014 (wallstreetpr) – Investment advisor, Goldman Sachs Group Inc (NYSE:GS) analysts have provided key takeaways from the 2014 Transcatheter Cardiovascular Therapeutics or TPT conference. Accordingly, they have retained their Buy rating on the shares of Abbott Pharmaceuticals (NYSE:ABT) and Edwards Lifesciences Corp (NYSE:EW) while they remained Neutral on St. Jude Medical, Inc. (NYSE:STJ) […]

Goldman Sachs Group Inc (NYSE:GS) Estimates Hospira, Inc. (NYSE:HSP) To Suffer EPS Loss Of 26 – 52 Cents In 2015 From Precedex Drug On Court Order

Boston, MA 09/12/2014 (wallstreetpr) – Investment advisor Goldman Sachs Group Inc (NYSE:GS) expects the injectable drug and infusion technologies provider Hospira, Inc. (NYSE:HSP) to lose 26 – 52 cents a share from Precedex in the next year after the court ruled in favor of generic competition recently. Major Factors                   In a research note to clients, […]

Sign Up To Get Our Latest Stocks Alerts